653 related articles for article (PubMed ID: 27788228)
1. Prevalence of Plasmodium falciparum Molecular Markers of Antimalarial Drug Resistance in a Residual Malaria Focus Area in Sabah, Malaysia.
Norahmad NA; Mohd Abd Razak MR; Abdullah NR; Sastu UR; Imwong M; Muniandy PK; Saat MN; Muhammad A; Jelip J; Tikuson M; Yusof N; Rundi C; Mudin RN; Syed Mohamed AF
PLoS One; 2016; 11(10):e0165515. PubMed ID: 27788228
[TBL] [Abstract][Full Text] [Related]
2. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
[TBL] [Abstract][Full Text] [Related]
3. Field-based evidence for linkage of mutations associated with chloroquine (pfcrt/pfmdr1) and sulfadoxine-pyrimethamine (pfdhfr/pfdhps) resistance and for the fitness cost of multiple mutations in P. falciparum.
Osman ME; Mockenhaupt FP; Bienzle U; Elbashir MI; Giha HA
Infect Genet Evol; 2007 Jan; 7(1):52-9. PubMed ID: 16690361
[TBL] [Abstract][Full Text] [Related]
4. Molecular markers associated with resistance to commonly used antimalarial drugs among Plasmodium falciparum isolates from a malaria-endemic area in Taiz governorate-Yemen during the transmission season.
Alareqi LMQ; Mahdy MAK; Lau YL; Fong MY; Abdul-Ghani R; Mahmud R
Acta Trop; 2016 Oct; 162():174-179. PubMed ID: 27343362
[TBL] [Abstract][Full Text] [Related]
5. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
[TBL] [Abstract][Full Text] [Related]
6. Molecular surveillance of Plasmodium falciparum drug resistance markers reveals partial recovery of chloroquine susceptibility but sustained sulfadoxine-pyrimethamine resistance at two sites of different malaria transmission intensities in Rwanda.
Kateera F; Nsobya SL; Tukwasibwe S; Hakizimana E; Mutesa L; Mens PF; Grobusch MP; van Vugt M; Kumar N
Acta Trop; 2016 Dec; 164():329-336. PubMed ID: 27647575
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of resistance associated polymorphisms in Plasmodium falciparum field isolates from southern Pakistan.
Ghanchi NK; Ursing J; Beg MA; Veiga MI; Jafri S; Mårtensson A
Malar J; 2011 Jan; 10():18. PubMed ID: 21272384
[TBL] [Abstract][Full Text] [Related]
8. Molecular monitoring of antimalarial drug resistance among Plasmodium falciparum field isolates from Odisha, India.
Das Sutar SK; Dhangadamajhi G; Kar SK; Ranjit M
Acta Trop; 2013 Apr; 126(1):84-7. PubMed ID: 23357175
[TBL] [Abstract][Full Text] [Related]
9. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
[TBL] [Abstract][Full Text] [Related]
10. Increased prevalence of the pfdhfr/phdhps quintuple mutant and rapid emergence of pfdhps resistance mutations at codons 581 and 613 in Kisumu, Kenya.
Spalding MD; Eyase FL; Akala HM; Bedno SA; Prigge ST; Coldren RL; Moss WJ; Waters NC
Malar J; 2010 Nov; 9():338. PubMed ID: 21106088
[TBL] [Abstract][Full Text] [Related]
11. Assessment of antimalarial drug resistant markers in asymptomatic Plasmodium falciparum infections after 4 years of indoor residual spraying in Northern Ghana.
Myers-Hansen JL; Abuaku B; Oyebola MK; Mensah BA; Ahorlu C; Wilson MD; Awandare G; Koram KA; Ngwa AA; Ghansah A
PLoS One; 2020; 15(12):e0233478. PubMed ID: 33284800
[TBL] [Abstract][Full Text] [Related]
12. Surveillance of molecular markers for antimalarial resistance in Zambia: Polymorphism of Pfkelch 13, Pfmdr1 and Pfdhfr/Pfdhps genes.
Sitali L; Mwenda MC; Miller JM; Bridges DJ; Hawela MB; Hamainza B; Mudenda-Chilufya M; Chizema-Kawesha E; Daniels RF; Eisele TP; Nerland AH; Chipeta J; Lindtjorn B
Acta Trop; 2020 Dec; 212():105704. PubMed ID: 33002448
[TBL] [Abstract][Full Text] [Related]
13. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
Dlamini SV; Beshir K; Sutherland CJ
Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
[TBL] [Abstract][Full Text] [Related]
14. Molecular Epidemiology of Drug Resistance Genes in Plasmodium falciparum Isolates Imported from Nigeria between 2016 and 2020: Continued Emergence of Fully Resistant
Wang X; Zhang X; Chen H; Zhang J; Lu Q; Ruan W; Ling F
Microbiol Spectr; 2022 Oct; 10(5):e0052822. PubMed ID: 36106887
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of mutations associated with antimalarial drugs in Plasmodium falciparum isolates prior to the introduction of sulphadoxine-pyrimethamine as first-line treatment in Iran.
Zakeri S; Afsharpad M; Raeisi A; Djadid ND
Malar J; 2007 Nov; 6():148. PubMed ID: 17999755
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
[TBL] [Abstract][Full Text] [Related]
17. Molecular monitoring of Plasmodium falciparum resistance to antimalarial drugs after adoption of sulfadoxine-pyrimethamine plus artesunate as the first line treatment in Iran.
Afsharpad M; Zakeri S; Pirahmadi S; Djadid ND
Acta Trop; 2012 Jan; 121(1):13-8. PubMed ID: 22001304
[TBL] [Abstract][Full Text] [Related]
18. Stable high frequencies of sulfadoxine-pyrimethamine resistance associated mutations and absence of K13 mutations in Plasmodium falciparum 3 and 4 years after the introduction of artesunate plus sulfadoxine-pyrimethamine in Ujjain, Madhya Pradesh, India.
Pathak A; Mårtensson A; Gawariker S; Sharma A; Diwan V; Purohit M; Ursing J
Malar J; 2020 Aug; 19(1):290. PubMed ID: 32795288
[TBL] [Abstract][Full Text] [Related]
19. High prevalence of Pfdhfr-Pfdhps quadruple mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Bioko Island, Equatorial Guinea.
Jiang T; Chen J; Fu H; Wu K; Yao Y; Eyi JUM; Matesa RA; Obono MMO; Du W; Tan H; Lin M; Li J
Malar J; 2019 Mar; 18(1):101. PubMed ID: 30914041
[TBL] [Abstract][Full Text] [Related]
20. Molecular epidemiology of drug resistance markers of Plasmodium falciparum in Yunnan Province, China.
Huang F; Tang L; Yang H; Zhou S; Liu H; Li J; Guo S
Malar J; 2012 Jul; 11():243. PubMed ID: 22839209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
